Science Corporation implants PRIMA vision chip in first Stargardt disease patient

Science Corporation, led by Max Hodak, has performed the first implantation of its PRIMA vision-restoring chip in a patient with Stargardt disease, an inherited retinal dystrophy. The system rebuilds vision by intervening directly in neural circuits at the hardware level.

• PRIMA is an implant designed to restore vision in retinal dystrophy
• This is the first procedure on a Stargardt disease patient
• The company is led by Neuralink co-founder Max Hodak